Abstract
AbstractFull sequencing of the GBA1 gene in patients with Parkinson’s disease provides a wide screening of pathogenic variants, but less developed regions of the world, like Latin America, may have difficulties in performing full sequencing. We performed a systematic review with meta-analysis to explore the prevalence and the odds ratio of specific GBA1 variants in Parkinson’s disease in Latin America. We noted a lack of full sequencing GBA1 studies in Latin America.
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology (clinical),Neurology
Reference17 articles.
1. Inzelberg, R., Hassin-Baer, S. & Jankovic, J. Genetic movement disorders in patients of Jewish ancestry. JAMA Neurol. 71, 1567–1572 (2014).
2. Huang, Y., Deng, L., Zhong, Y. & Yi, M. The Association between E326K of GBA and the Risk of Parkinson’s Disease. Parkinsons Dis. 2018, 1048084 (2018).
3. Woo, E. G., Tayebi, N. & Sidransky, E. Next-Generation Sequencing Analysis of GBA1: The Challenge of Detecting Complex Recombinant Alleles. Front. Genet. 12, 684067 (2021).
4. Leija-Salazar, M. et al. Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION. Mol. Genet. Genom. Med. 7, e564 (2019).
5. den Heijer, J. M. et al. A Large-Scale Full GBA1 Gene Screening in Parkinson’s Disease in the Netherlands. Mov. Disord. 35, 1667–1674 (2020).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献